These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fetal cell transplants: special report. Concar D; Ainsworth C; Young E New Sci; 2001 Mar; 169(2283):10-1. PubMed ID: 12549478 [No Abstract] [Full Text] [Related]
3. Trial and error. New Sci; 2001 Mar; 169(2283):3. PubMed ID: 12549477 [No Abstract] [Full Text] [Related]
4. Donor-containing cortical and intraventricular glioneuronal nodules in Huntington's disease brain decades after fetal cell transplantation. Pinarbasi ES; Liu EA; Yu Z; Kopyov O; Brown NA; Dayalu P; Lieberman AP Acta Neuropathol; 2021 Jun; 141(6):979-981. PubMed ID: 33683397 [No Abstract] [Full Text] [Related]
5. Dyskinesias after transplantation in Parkinson's disease. Piccini P Lancet Neurol; 2002 Dec; 1(8):472. PubMed ID: 12849327 [No Abstract] [Full Text] [Related]
6. Neural transplantation for the treatment of Parkinson's disease. Björklund A; Dunnett SB; Brundin P; Stoessl AJ; Freed CR; Breeze RE; Levivier M; Peschanski M; Studer L; Barker R Lancet Neurol; 2003 Jul; 2(7):437-45. PubMed ID: 12849125 [No Abstract] [Full Text] [Related]
7. Benefits and risks of hosting animal cells in the human brain. Isacson O; Breakefield XO Nat Med; 1997 Sep; 3(9):964-9. PubMed ID: 9288721 [No Abstract] [Full Text] [Related]
8. Graft-induced dyskinesias in Parkinson's disease: what is it all about? Barker RA; Kuan WL Cell Stem Cell; 2010 Aug; 7(2):148-9. PubMed ID: 20682443 [TBL] [Abstract][Full Text] [Related]
15. Neural transplantation (auto-adrenal, fetal nigral and fetal adrenal) in Parkinson's disease: the Mexican experience. Madrazo I; Franco-Bourland R; Ostrosky-Solis F; Aguilera M; Cuevas C; Alvarez F; Magallon E; Zamorano C; Morelos A Prog Brain Res; 1990; 82():593-602. PubMed ID: 1981281 [No Abstract] [Full Text] [Related]
16. Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease. Mamelak AN; Eggerding FA; Oh DS; Wilson E; Davis RL; Spitzer R; Hay JA; Caton WL J Neurosurg; 1998 Oct; 89(4):592-8. PubMed ID: 9761053 [TBL] [Abstract][Full Text] [Related]
17. Status of fetal tissue transplantation for the treatment of advanced Parkinson disease. Greene PE; Fahn S Neurosurg Focus; 2002 Nov; 13(5):e3. PubMed ID: 15769072 [TBL] [Abstract][Full Text] [Related]
18. Ethical challenges in cell-based interventions for neurological conditions: some lessons to be learnt from clinical transplantation trials in patients with Parkinson's disease. Hildt E Am J Bioeth; 2009 May; 9(5):37-8. PubMed ID: 19396682 [No Abstract] [Full Text] [Related]
19. The future of cell therapies in the treatment of Parkinson's disease. Laguna Goya R; Kuan WL; Barker RA Expert Opin Biol Ther; 2007 Oct; 7(10):1487-98. PubMed ID: 17916042 [TBL] [Abstract][Full Text] [Related]
20. Prolonged postlesion transplantation delay adversely influences survival of both homotopic and heterotopic fetal hippocampal cell grafts in Kainate-lesioned CA3 region of adult hippocampus. Zaman V; Turner DA; Shetty AK Cell Transplant; 2001; 10(1):41-52. PubMed ID: 11294471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]